Related Experiment Video
Updated: Feb 15, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
miRNAs as Potential Treatment Targets and Treatment Options in Cancer
Nina Petrovic1,2, Sercan Ergun3,4
1Department for Radiobiology and Molecular Genetics, Vinca Institute of Nuclear Sciences, University of Belgrade, Mike Alasa 12-14, 11000, Belgrade, Serbia. dragoninspiration@yahoo.com.
Abstract:
Standard cancer therapies for solid malignancies, such as chemotherapy and radiotherapy, are not target specific against cancer cells and are often not fully efficacious. Chemotherapy and radiotherapy may cause side effects, and the need to develop additional strategies for cancer treatment is urgent. MicroRNAs (miRNAs) are small non-coding RNAs with heterogeneous functions and have been described in almost every known cancer model. Besides their basic tumor-suppressive and oncogenic functions, they also have the potential to modulate chemotherapy and radiotherapy and to be manipulated with chemical compounds to make them chemically suitable for efficient delivery to cancer cells. It has been suggested that the level of expression of specific miRNAs could increase treatment efficacy by determining the stage of chemotherapy/radiotherapy sensitivity. Application of miRNAs alone or in combination with standard therapeutic strategies may significantly improve the success of cancer treatments in the future.
Insights
MicroRNAs (miRNAs) show promise in cancer treatment by enhancing chemotherapy and radiotherapy efficacy. These small non-coding RNAs can be manipulated for targeted delivery, potentially improving cancer therapy success.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Standard cancer therapies like chemotherapy and radiotherapy lack specificity and efficacy against solid tumors.
- These conventional treatments can cause significant side effects, highlighting the urgent need for novel therapeutic strategies.
- MicroRNAs (miRNAs), small non-coding RNAs, play diverse roles in cancer, acting as tumor suppressors or oncogenes.
Purpose of the Study:
- To explore the potential of microRNAs (miRNAs) as adjuncts or standalone therapies in cancer treatment.
- To investigate the role of miRNAs in modulating the efficacy of chemotherapy and radiotherapy.
- To assess the feasibility of chemically modifying miRNAs for improved delivery and therapeutic application.
Main Methods:
- Review of existing literature on miRNA functions in cancer.
- Analysis of miRNA expression patterns in relation to chemotherapy and radiotherapy sensitivity.
- Exploration of chemical modification strategies for miRNA delivery.
Main Results:
- MicroRNAs (miRNAs) exhibit tumor-suppressive and oncogenic functions in various cancer models.
- Specific miRNA expression levels correlate with sensitivity to chemotherapy and radiotherapy.
- Chemical modifications can enhance the stability and delivery of miRNAs for therapeutic use.
Conclusions:
- MicroRNAs (miRNAs) hold significant potential to improve the efficacy of existing cancer treatments.
- Targeted application of miRNAs, alone or in combination with standard therapies, could enhance cancer treatment outcomes.
- Further research into miRNA-based therapies is warranted to overcome limitations of current cancer treatments.
Related Concept Videos
Treatment Resistant Cancers
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Alzheimer's Disease: Treatment
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Angle Closure Glaucoma: Treatment

